PharmacoEconomics

Cost-of-Illness Studies: Useful for Health Policy?
pp. 143-148(6)
Author: Koopmanschap M.A.

Update on Clinical Research Summit in US
pp. 149-150(2)
Authors: Moskowitz J.; Thompson J.N.

The Role of Clinical Pathways in Reducing the Economic Burden of Stroke
pp. 151-158(8)
Author: Lanska D.J.

Reporting Format for Economic Evaluation: Part I: Application to the Dutch Healthcare System
pp. 159-163(5)
Authors: Nuijten M.J.C.; Brorens M.J.A.; Hekster Y.A.; van der Kuy A.; Lockefeer J.H.M.; de Smet P.A.G.M.; Bonsel G.; Pronk M.H.

Cost Effectiveness of Prophylaxis for Opportunistic Infections in AIDS: An Overview and Methodological Discussion
pp. 165-174(10)
Authors: Freedberg K.A.; Paltiel A.D.

A Review of the Pharmacoeconomics of Pharmaceutical Care
pp. 175-189(15)
Authors: Plumridge R.J.; Wojnar-Horton R.E.

Choice of NSAID and Management Strategy in Rheumatoid Arthritis and Osteoarthritis: The Impact on Costs and Outcomes in the UK
pp. 191-199(9)
Authors: McCabe C.J.; Akehurst R.L.; Kirsch J.; Whitfield M.; Backhouse M.; Woolf A.D.; Scott D.L.; Emery P.; Haslock I.

Quality of Life Following a Change in Therapy for Diabetes Mellitus
pp. 201-207(7)
Authors: Pibernik-Okanovi M.; Szabo S.; Melko Z.

Cost Effectiveness of Screening for Subclinical Hypothyroidism in the Elderly: A Decision-Analytical Model
pp. 209-216(8)
Authors: Bona M.; Santini F.; Rivolta G.; Grossi E.; Grilli R.

Pravastatin: A Pharmacoeconomic Review of its use in Primary and Secondary Prevention of Coronary Heart Disease
pp. 217-236(20)
Authors: Coukell A.J.; Wilde M.I.